Genelux (GNLX) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

Genelux Revenue Highlights


Latest Revenue (Y)

$170.00K

Latest Revenue (Q)

$8.00K

Genelux Revenue by Period


Genelux Revenue by Year

DateRevenueChange
2023-12-31$170.00K-98.46%
2022-12-31$11.07M100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Genelux generated $170.00K in revenue during NA 2023, up -98.46% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Genelux Revenue by Quarter

DateRevenueChange
2024-03-31$8.00K-99.45%
2023-12-31$1.46M100.00%
2023-09-30-100.00%
2023-06-30--100.00%
2023-03-31$170.00K150.00%
2022-12-31$68.00K-99.38%
2022-09-30$11.00M100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Genelux generated $8.00K in revenue during Q1 2024, up -99.45% compared to the previous quarter, and up 11.76% compared to the same period a year ago.

Genelux Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
AMLXAmylyx Pharmaceuticals$380.79M$88.64M
IVAInventiva$17.50M$15.58M
NAMSNewAmsterdam Pharma Company$14.09M$1.40M
IKNAIkena Oncology$9.16M-
CNTACentessa Pharmaceuticals$6.88M-
DYAIDyadic$2.90M$334.62K
GNLXGenelux$170.00K$8.00K
CGEMCullinan Oncology--
IMRXImmuneering--
DAWNDay One Biopharmaceuticals-$20.07M
CINGCingulate--
ABOSAcumen Pharmaceuticals--
TERNTerns Pharmaceuticals--
CELCCelcuity--
LRMRLarimar Therapeutics--
MNPRMonopar Therapeutics--
GLUEMonte Rosa Therapeutics-$4.70M
CMPXCompass Therapeutics--
MLTXMoonLake Immunotherapeutics--

GNLX Revenue FAQ


Genelux's yearly revenue for 2023 was $170K, representing a decrease of -98.46% compared to 2022. The company's yearly revenue for 2022 was $11.07M, representing an increase of 100.00% compared to 2021. GNLX's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

Genelux's quarterly revenue for Q1 2024 was $8K, a -99.45% decrease from the previous quarter (Q4 2023), and a -95.29% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $1.46M, a 100.00% increase from the previous quarter (Q3 2023), and a 2052.94% increase year-over-year (Q4 2022). GNLX's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a -100.00% decrease year-over-year (Q3 2022).

Genelux's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.